Illumina sets response timeline to Roche offer

(Reuters) - U.S. gene sequencing company Illumina Inc said on Friday it will tell shareholders within 10 business days of its position on a $5.7 billion takeover bid from Swiss drugmaker Roche Holding AG. In the meantime, Illumina advised sharehol...